Modulation of effector caspase cleavage determines response of breast and lung tumor cell lines to chemotherapy

Cancer Investigation

Volumn 27, Issue 4, 2009, Pages 417-429

  Odonkor, Charles A ^a   Achilefu, Samuel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase; Drug resistance; Paclitaxel; Temporal response

Indexed keywords

CASPASE 3; CASPASE 7; EFFECTOR CASPASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; ANTINEOPLASTIC AGENT; CASP3 PROTEIN, HUMAN; CASP7 PROTEIN, HUMAN; CYSTEINE PROTEINASE INHIBITOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MODULATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; BREAST TUMOR; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; LUNG TUMOR; METABOLISM; PATHOLOGY; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; FEMALE; HUMANS; LUNG NEOPLASMS; PACLITAXEL; POLY(ADP-RIBOSE) POLYMERASES; TIME FACTORS;

EID: 65249097854     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802438585     Document Type: Article

References (35)

1. Parkin, D.M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55(2), 74-108.
2. Yoh, K.; Ishii, G.; Yokose, T.; Minegishi, Y; Tsuta, K.; Goto, K.; Nishiwaki, Y; Kodama, T.; Suga, M.; Ochiai, A. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin. Cancer Res. 2004, 10(5), 1691-1697.
3. Gee, M.S.; Upadhyay, R.; Bergquist, H.; Weissleder, R.; Joseph- son, L; Mahmood, U. Multiparameter noninvasive assessment of treatment susceptibility, drug target inhibition and tumor response guides cancer treatment. Int. J. Cancer 2007,727(11), 2492-2500.
4. Janssen, K.; Pohlmann, S.; Janicke, R.U.; Schulze-Osthoff, K.; Fischer, U. Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood 2007, 110(10), 3662-3672.
5. Wieder, T.; Essmann, F.; Prokop, A.; Schmelz, K.; Schulze-Osthoff, K.; Beyaert, R.; Dorken, B.; Daniel, P. T. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 2001, 97(5), 1378-1387.
6. Thornberry, N.A. Caspases: key mediators of apoptosis. Chem. Biol 1998, 5(5), R97-103.
7. Dlamini, Z.; Mbita, Z.; Ledwaba, T. Can targeting apoptosis resolve the cancer saga? Future Oncol. 2005, 1(3), 339-349.
8. Green, D.R.; Evan, G.I. A matter of life and death. Cancer Cell. 2002, 7(1), 19-30.
9. Lu, X.; Arthur, G. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids. Cancer Res. 1992, 52(10), 2813-2817.
10. Duan, W.R.; Garner, D.S.; Williams, S.D.; Funckes-Shippy, C. L; Spath, I. S.; Blomme, E. A. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J. Pathol. 2003, 199(2), 221- 228.
11. Sanghavi, D.M.; Thelen, M.; Thornberry, N.A.; Casciola-Rosen, L; Rosen, A. Caspase-mediated proteolysis during apoptosis: insights from apoptotic neutrophils. FEBS Lett. 1998, 422(2), 179- 184.
12. Achilefu, S.; Bloch, S.; Markiewicz, M.A.; Zhong, T; Ye, Y; Dorshow, R. B.; Chance, B.; Liang, K. Synergistic effects of light- emitting probes and peptides for targeting and monitoring inte- grin expression. Proc. Natl. Acad. Sci. USA 2005, 102(22), 7976- 7981.
13. Coxon, J.P.; Oades, G.M.; Kirby, R.S.; Colston, K.W. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation. BJU Int. 2004, 94(1), 164-170.
14. Hiraga, T; Williams, P.J.; Ueda, A.; Tamura, D.; Yoneda, T. Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin. Cancer Res. 2004, 70(13), 4559- 4567.
15. Zeng, H.; Wei, Q.; Huang, R.; Chen, N.; Dong, Q.; Yang, Y; Zhou, Q. Recombinant adenovirus mediated prostate-specific enzyme pro-drug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter. J. Androl. 2007, 23(6), 827- 835.
16. Zeng, Z.; Yuan, X.; Liu, G.; Zeng, X.; Zeng, X.; Ng, H.; Chen, H.; Jiang, T; Akasaki, Y; Kessey, K.; Black, K. L.; Yu, J. S. Manipulation of proliferation and differentiation of human bone marrow-derived neural stem cells in vitro and in vivo. J. Neurosci. Res. 2007,85(2), 310-320.
17. Kerr, L. E.; Birse-Archbold, J. L; Simon, A.; Logan, N.; Scott, F.; Carlson, G.; Nicholson, D. W.; Kelly, J. S.; Sharkey, J. Differential regulation of caspase-3 by pharmacological and developmental stimuli as demonstrated using humanised caspase-3 mice. Apoptosis 2004, 9(6), 739-747.
18. Li, R.; Moudgil, T; Ross, H.J.; Hu, H.M. Apoptosis of non-small- cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell. Death Differ. 2005, 72(3), 292-303.
19. Liebmann, J. E.; Cook, J. A.; Lipschultz, C; Teague, D.; Fisher, J.; Mitchell, J. B. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br. J. Cancer 1993, 68(6), 1104-1109.
20. Rossi, D.; Gaidano, G. Messengers of cell death: apoptotic signaling in health and disease. Haematologica 2003, 88(2), 212-218.
21. Perkins, C; Kim, C.N.; Fang, G.; Bhalla, K.N. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells. Cancer Res. 1998, 58(20), 4561- 4566.
22. Perkins, C.L; Fang, G.; Kim, C.N.; Bhalla, K.N. The role of Apaf- 1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res. 2000, 60(6), 1645-1653.
23. Ponnathpur, V.; Ibrado, A. M.; Reed, J. C; Ray, S.; Huang, Y; Self, S.; Bullock, G.; Nawabi, A.; Bhalla, K. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein. Clin. Cancer Res. 1995, 1(11), 1399-1406.
24. Schiff, P.B.; Horwitz, S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 1980, 77(3), 1561- 1565.
25. Schiller, J.H.; Harrington, D.; Belani, CP; Langer, C; Sandler, A.; Krook, J.; Zhu, J.; Johnson, D.H. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N. Engl. J. Med. 2002, 346(2), 92-98.
26. Parkin, D.M.; Bray, F.I.; Devesa, S.S. Cancer burden in the year 2000. The global picture. Eur. J. Cancer 2001, 37(Suppl 8), S4- S66.
27. Goncalves, A.; Braguer, D.; Kamath, K.; Martello, L; Briand, C; Horwitz, S.; Wilson, L; Jordan, M.A. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. USA 2001, 98(20), 11737-11742.
28. Hei, T.K.; Hall, E.J. Taxol, radiation, and oncogenic transformation. Cancer Res. 1993, 53(6), 1368-1372.
29. McCloskey, D.E.; Armstrong, D.K.; Jackisch, C; Davidson, N.E. Programmed cell death in human breast cancer cells. Recent Prog. Horm. Res. 1996, 51, 493-508.
30. Nicholson, D.W.; Ali, A.; Thornberry, N.A.; Vaillancourt, J.P.; Ding, C.K.; Gallant, M.; Gareau, Y; Griffin, PR.; Labelle, M.; Lazeb- nik, Y.A.; Munday, N.A.; Raju, S.M.; Smulson, M.E.; Yamin, T.T.; Yu, V.L; Miller, D.K. Identification and inhibition of the ICE/CED- 3 protease necessary for mammalian apoptosis. Nature 1995, 376(6535), 37-43.
31. Park, S.J.; Wu, C.H.; Gordon, J.D.; Zhong, X.; Emami, A.; Safa, A.R. Taxol induces caspase-10-dependent apoptosis. J. Biol. Chem. 2004, 279(49), 51057-51067.
32. Weigel, T.L; Lotze, M.T.; Kim, P.K.; Amoscato, A.A.; Luketich, J.D.; Odoux, C. Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity. J. Thorac. Cardiovasc. Surg. 2000, 119(4 Pt 1), 795-803.
33. Broker, L.E.; Huisman, C; Span, S.W.; Rodriguez, J.A.; Kruyt, F.A.; Giaccone, G. Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res. 2004, 64(1), 27-30.
34. Huisman, C; Ferreira, C.G.; Broker, L.E.; Rodriguez, J.A.; Smit, E.F.; Postmus, P.E.; Kruyt, F.A.; Giaccone, G. Paclitaxel triggers cell death primarily via caspase-independent routes in the non- small cell lung cancer cell line NCI-H460. Clin. Cancer Res. 2002, 8(2), 596-606.
35. Soung, Y.H.; Lee, J.W.; Kim, S.Y; Park, W.S.; Nam, S.W.; Lee, J.Y.; Yoo, N.J.; Lee, S.H. Somatic mutations of CASP3 gene in human cancers. Hum. Genet. 2004, 115(2), 112-115.